×
About 170 results

ALLMedicine™ Gynecologic Oncology Center

Research & Reviews  58 results

New Targeted Therapies and Combinations of Treatments for Cervical, Endometrial, and Ov...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027198
Current Oncology (Toronto, Ont.); Gheorghe AS, Dumitrescu EA et. al.

Apr 22nd, 2022 - This review of the meaningful data from 2021 on cervical, endometrial, and ovarian cancers aims to provide an update of the most clinically relevant studies presented at important oncologic congresses during the year (the American Society of Clini...

Informed consent forms for gynecologic cancer surgery: recommendations from the Korean ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899870
Journal of Gynecologic Oncology; Chang HK, Shim SH et. al.

Mar 5th, 2022 - The sociomedical environment is changing. In the traditional physician-patient relationship, the physician was authoritative and the patient was obedient. The contractual relationship featured patient consent to the physician's decision. Today, th...

Association of gynecologic oncology versus medical oncology specialty with survival, ut...
https://doi.org/10.1016/j.ygyno.2021.12.001
Gynecologic Oncology; Ko EM, Bekelman JE et. al.

Dec 25th, 2021 - We examined the association of gynecologic oncology (GYO) versus medical oncology (MEDONC) based care with survival, health care utilization and spending outcomes in women undergoing chemotherapy for advanced gynecologic cancers. Women with newly ...

Impact of COVID-19 on gynecologic cancer treatment in Japan: a nationwide survey by the...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728672
Journal of Gynecologic Oncology; Nogami Y, Komatsu H et. al.

Nov 17th, 2021 - As coronavirus disease 2019 (COVID-19) rages on, it is a challenging task to balance resources for treatment of COVID-19 and malignancy-based treatment. For the development of optimal strategies, assessing the conditions and constrains in treatmen...

Updated clinical guideline for human papillomavirus vaccine: the Korean Society of Gyne...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550930
Journal of Gynecologic Oncology; Cho HW, Min KJ et. al.

Oct 29th, 2021 - Since the human papillomavirus (HPV) vaccine guidelines were developed by the Korean Society of Gynecologic Oncology (KSGO) in 2011, 2016, and 2019, several recent studies on the efficacy and safety of HPV vaccines in middle-aged women and men hav...

see more →

Guidelines  3 results

Japan Society of Gynecologic Oncology guidelines 2017 for the treatment of uterine cerv...
https://doi.org/10.1007/s10147-018-1351-y
International Journal of Clinical Oncology; Ebina Y, Mikami M et. al.

Oct 7th, 2018 - The Japan Society of Gynecologic Oncology (JSGO) Guidelines 2017 for the Treatment of Uterine Cervical Cancer are for the purpose of providing standard treatment strategies for cervical cancer, indicating treatment methods currently considered app...

Practice guidelines for management of ovarian cancer in Korea: a Korean Society of Gyne...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5981107
Journal of Gynecologic Oncology; Suh DH, Chang SJ et. al.

May 18th, 2018 - Since after 2006 when the first edition of practice guidelines for gynecologic oncologic cancer treatment was released, the Korean Society of Gynecologic Oncology (KSGO) has published the following editions on a regular basis to suggest the best p...

Evidence-based guidelines for treatment of uterine body neoplasm in Japan: Japan Societ...
https://doi.org/10.1007/s10147-010-0138-6
International Journal of Clinical Oncology; Nagase S, Katabuchi H et. al.

Nov 12th, 2010 - Endometrial carcinoma is one of the most common gynecologic malignancies in Japan and its incidence has increased recently. Although surgery is the cornerstone of the management of patients with endometrial cancer, there is significant variation i...

see more →

News  7 results

Surgery to Reduce Ovarian Cancer Risk — One Step or Two?
https://www.staging.medscape.com/viewarticle/910898

Mar 25th, 2019 - HONOLULU — High-risk women who undergo prophylactic surgery to reduce ovarian cancer risk have few lingering worries about developing cancer in the future or regrets about their decision to undergo that surgery, suggest results from two studies. T...

Surgery to Reduce Ovarian Cancer Risk — One Step or Two?
https://www.medscape.com/viewarticle/910898

Mar 25th, 2019 - HONOLULU — High-risk women who undergo prophylactic surgery to reduce ovarian cancer risk have few lingering worries about developing cancer in the future or regrets about their decision to undergo that surgery, suggest results from two studies. T...

TWiST Strengthens PARP Inhibitor Role in Ovarian Cancer
https://www.medscape.com/viewarticle/910546

Mar 18th, 2019 - HONOLULU — A new analysis of the phase 3 NOVA trial strengthens earlier findings that niraparib (Zejula, Tesaro) provides meaningful clinical benefit for patients with platinum-sensitive, recurrent ovarian cancer compared with placebo by prolongin...

When is it appropriate to remove ovaries in hysterectomy?
https://www.mdedge.com/surgery/article/190921/surgery/when-it-appropriate-remove-ovaries-hysterectomy?channel=39313
Randy Dotinga

Dec 11th, 2018 - LAS VEGAS – The removal of both ovaries during hysterectomy – bilateral salpingo-oophorectomy (BSO) – has declined sharply in popularity as physicians have become more aware of its risks. Courtesy Cashman Photo Dr.

HPV Test for First-line Cervical Screen: Questions on Use
https://www.medscape.com/viewarticle/824277

Apr 29th, 2014 - When the cobas HPV Test (Roche Molecular Systems) was approved for first-line screening of primary cervical cancer by the US Food and Drug Administration (FDA) last week, how and when it should be used was not addressed. "We are aware that the app...

see more →